Author:
Sussman Jeffrey J.,Shu Suyu,Sondak Vernon K.,Chang Alfred E.
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Hersh EM, Taylor CW. Immunotherapy by active immunization: use of nonspecific stimulants and immunomodulators. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Philadelphia: JB Lippincott, 1991;613–26.
2. Lotze MT, Chang AE, Seipp CA, Simpson C, Vetto JT, Rosenberg SA. High-dose recombinant interleukin-2 in the treatment of patients with disseminated cancer.JAMA 1986;256:3117–24.
3. Rosenberg SA, Lotze MT, Yang JC, et al. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients.Ann Surg 1989;210:474–85.
4. Sosman JA, Kohler PC, Hank J, et al. Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicity.JNCI 1988;80:60–3.
5. Parkinson DR, Abrams JS, Wiernik PH, et al. Interleukin-2 therapy in patients with metastatic malignant melanoma: a Phase II study.J Clin Oncol 1990;8:1650–6.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献